Approval · Notice of Compliance 12524 · 2011
OPTION 2: Notice of Compliance 12524
Issued August 5, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12524
- Date
- August 5, 2011
- Company
- Perrigo International, Inc.Allegan, Michigan, United States
- Product type
- Nonprescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Emergency Contraception
- Canadian reference product
- PLAN B (Duramed Pharmaceuticals, Inc., A Subsidiary Of Barr Pharmaceuticals, Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OPTION 2 | 02371189 | Cancelled Post Market |
Medicinal ingredients
- LEVONORGESTREL 0.75 MG per TAB